Untitled video

JK
by Jessica Kindynis2 views·Updated Nov 28, 2020

Audio TranscriptAuto-generated

  1. hi there.
  2. I hope you're excited to learn something new today.
  3. In the landscape of medical cannabis for chronic pain, GPS
  4. have reported a more than 65% increase in chronic pain
  5. presentations in the past decade.
  6. Given the health concerns and addiction risks associated with common
  7. only prescribed pharmaceuticals for pain like nonsteroidal anti inflammatories and
  8. opioids, medical professionals and patients are looking to cannabinoids to
  9. manage chronic pain.
  10. As of October 2020 the TJ is approved more than
  11. 72,000 medical cannabis applications.
  12. Private sector data suggests that up to 80% of that
  13. could relate to pain presentations.
  14. So let's jump into this topic starting with the Indo
  15. cannabinoid system.
  16. We'll look at this integral body system before we assess
  17. how we can target it to optimize chronic pain management.
  18. Cannabinoid receptor Canavan Hide researcher Professor Vince Enzo de Marzo
  19. summarizes the Indo cannabinoid system in five words.
  20. Eat, sleep, relax, forget and protect.
  21. The end of cannabinoid system, or CCS, is present in
  22. all vertebrate animals and is an integral regulator in home
  23. yo Stasis throughout the body.
  24. The CS begins establishing from 14 weeks gestation in humans
  25. and is essential in the initial formation of neuronal connectivity.
  26. In general, it has influence over the activity of digestive
  27. and endocrine hormones, the immune and nervous systems the body
  28. produces. Endogenous cannabinoids that interact with this system and exogenous
  29. cannabinoids from cannabis also have potent actions.
  30. Yet it might surprise you to know there are a
  31. number of other herbs that have Canada Memet IQ qualities
  32. or otherwise interact with the E.
  33. C s al calamities in the echinacea species interact directly
  34. with the E.
  35. C s fire cannabinoid receptors one and two, which may
  36. have implications for inflammatory conditions and immune function by mediating
  37. actions of intelligence and Truman of courses Factor Alfa.
  38. There are a number of other plants that are agonist
  39. for PCs, receptors or impact enzymatic processes in the system.
  40. But for now, let's move on to components of the
  41. entire cannabinoid system.
  42. I won't spend long here, but I felt this is
  43. a great example of the complexities of the under cannabinoid
  44. system. This image shows the reactions between cannabinoids, receptors, enzymes
  45. and a whole range of other processes in a single
  46. cell. While this is an artist interpretation, it's largely biologically
  47. accurate and gives an understanding of the huge influence of
  48. the CS and its components.
  49. Given I've already mentioned receptors, let's stop there.
  50. The two key ones in the E.
  51. C s a G protein coupled receptors, namely cannabinoid receptors,
  52. C B one and C B two.
  53. There are a number of other part G protein receptors
  54. that play a role, but that's outside of today's scope.
  55. Both receptors have found systemically in the body.
  56. They have different areas of density if you like.
  57. CB one receptors are abundant in the brain and nervous
  58. system, and ah, primarily famous for their interactions with Delta.
  59. Nine th see Facilitating the intoxicating effects of cannabis CB
  60. one receptors contribute to maintaining home your Stasis via processes
  61. in the nervous and endocrine system.
  62. In influencing serotonin, dopamine and HP a access pathways, they
  63. have both the direct and indirect role in mood, sleep,
  64. stress, pain and more.
  65. CB one receptors are found in the cardiovascular and digestive
  66. systems in the heart.
  67. CB one receptors more moderate dilation and contraction and vessels
  68. thereby maintaining blood pressure.
  69. And in the gastrointestinal tract, they have influence over appetite
  70. hormones, motility and digestive secretions.
  71. CB two receptors do not market modulate You forgot intoxicating
  72. effects. But they do have a strong presence in the
  73. immune and reproductive systems, their key mediators in the regulation
  74. of inflammation, pain and the integrity nervous system, while in
  75. the skeletal system they modulate bone density through supporting osteoblasts
  76. and osteoclasts.
  77. O Genesis.
  78. There are a number of other receptors that act in
  79. this CCS symphony.
  80. Get only a few more.
  81. Get our honorary mention here and that it's serotonin receptors.
  82. Tr P V s and P p a r S
  83. T L P V one receptor accounts for the mechanistic
  84. action of Indo Cannabinoids and CBD and pain presentations in
  85. part and P P.
  86. A. Receptors are thought to play roles in both inflammation
  87. Neuro protection whilst five ht three receptor activation by Ananda
  88. Meid results in analgesia, the next component of the Indo
  89. cannabinoids, the two most abundant and well researched and oh
  90. cannabinoids are Ananda Mydd and to a rack.
  91. O'Donnell, Glycerol or to a G to E.
  92. J. Has a high affinity for both receptors, with basil
  93. levels approximately 1000 times higher than Ananta Mind, which has
  94. a lower affinity for CB one receptors in an even
  95. lower affinity for C B two to age is thought
  96. to have rain over the brain and nervous system while
  97. in an demise influences spread more systemically.
  98. There are a number of other inter cannabinoids, such as
  99. P E A and N a d A, both of
  100. which have relevance to pain processes and inflammation.
  101. The final component of the CS for today.
  102. The enzymes involved in regulating its function n a p
  103. e is the synthesizing enzyme.
  104. Fernanda Mydd and P I.
  105. P two enzymes build to a G fatty acid, amino
  106. hydrolyzed and moderate pays of the primary Who were the
  107. primary? Oh fatty acid and Maynor Hydra lays and monitor
  108. Astle glycerol lie pays at the primary enzymes in the
  109. breakdown of an anti mine into a G respectively.
  110. Though there are other metabolic pathways in which they integrated
  111. Now that we have a bit of an understanding of
  112. the E.
  113. C s.
  114. Let's look at cannabinoids seen here in light green is
  115. Delta nine th see the most commonly talked about cannabinoid,
  116. preclinical and animal trials show it to have analgesic, anti
  117. inflammatory and anti a medic action on top of its
  118. infamous youf orient or intoxicating effects, CBD is most well
  119. known for its anti left, anti epileptic and anti convulsant
  120. action. However, it's also known to have an algae sick
  121. politic antipsychotic, antioxidant, anti spasmodic, important anti inflammatory actions.
  122. I'd like to make it an important right here on
  123. psycho activity.
  124. I find this time is often mislabeled in the academic
  125. and medical community alike, with most sources stating CBT to
  126. be non psychoactive.
  127. This is, in fact, a misrepresentation.
  128. Psycho activity determines the substance has an action on hormones
  129. or nervous system, signaling that influences cognition, mood or behaviors.
  130. Given CBD has an excellent qualities attributed in part to
  131. its influence over serotonin pathways.
  132. It and other cannabinoids should truly be labeled psychoactive.
  133. However, unlike Delta nine th c and a few others,
  134. they are non intoxicating.
  135. Moving on there are over 100 cannabinoids.
  136. Some others include T H C A and C B
  137. D A.
  138. The Pacific precursors, for which all others T H C
  139. and C B D type compounds are derived.
  140. Minor cannabinoids with potential energetic action include C B D,
  141. A, C B, C, C, B G, Delta 80 HC,
  142. Delta, T, H, C V and the recently discovered T
  143. H C P.
  144. You'll also see Turpin's here.
  145. Turbines are important features in medical cannabis formulations, so it
  146. means like Huma Lane beta carry off.
  147. Elaine MasseyEn have analgesic and anti inflammatory actions that can
  148. contribute to pain relief.
  149. Together, Cannabinoids, Turpin's and other photo chemicals engage in a
  150. phenomenon known as the entourage effect, whereby cannabinoids accent logistically
  151. with one another to create greater or different effects than
  152. they would in isolation.
  153. For Marco Kinetics of cannabinoids air vary depending on the
  154. route of administration.
  155. Medical cannabis can come in capsules, oils, sublingual, sprays, patches,
  156. dissolvable wafers, rectal suppositories and more.
  157. The traditional inhalation offers the most optimal.
  158. Bio availability, however, comes with obvious risks.
  159. Thus Orel and sublingual applications of the most commonly utilized
  160. in practice, Orel and Sublingual bio availability ranges from 2
  161. to 14%.
  162. Mucosal absorption in the mouth limits.
  163. First possible metabolism in this case and therefore improved by
  164. availability compared to gastrointestinal absorption inhalation by smoking and vaporization
  165. offers 10 to 35% of our availability.
  166. Transdermal applications are difficult to measure, but CBD seems to
  167. have a tenfold high absorption through the skin.
  168. The th see off the Malik administration between four and
  169. 60% and rectal, approximately 13% in general, with cannabinoids by
  170. availability, can be quite erratic and subject to into individual
  171. variations, especially when comparing cannabis naive individuals to experience users.
  172. The lipo flicked nature of cannabinoids mobile why they distributed,
  173. and vascular rised tissue, including the heart, lungs, spleen, kidney
  174. muscles and at a post tissue onset of action, peak
  175. plasma levels and duration of therapeutic effect differ greatly depending
  176. on the route of administration.
  177. Cannabinoids metabolized primarily by C Y P 4 50 enzymes
  178. for T H C.
  179. That is predominantly C Y P tune C nine to
  180. C 19 and 384 for C B D.
  181. C Y P three a four to C 19 of
  182. the main ones and in terms of elimination, cannabinoids of
  183. primarily excreted through the feces but also, uh, a smaller
  184. met through the urine.
  185. So what does the research say about medical cannabis for
  186. pain? The evidence is promising.
  187. All those still mixed enoughto warrant further investigations.
  188. This is attributed to varied photochemical profiles endorsing of formulations,
  189. a ZX well as differences in types of pain that
  190. have been investigated in the 2018 try, A 177 patients
  191. with treatment resistant cancer pain, 43% showed a 30% reduction
  192. in pain scores, while 30% may not seem large in
  193. terms of chronic pain management, it is clinically significant value.
  194. A small study of fibromyalgia patients reported 50% to be
  195. able to cease their pain medications.
  196. And there's plenty of supporting evidence for medical cannabis in
  197. pain and inflammation that's associated with arthritic conditions.
  198. In terms of CBD, solid amounts of human clinical data
  199. is still lacking, although it seems to be effective, especially
  200. neuropathic pain.
  201. UH, numerous examples for CBD to be more effective and
  202. algae sick when combined with even small amounts of th
  203. C or other cannabinoids.
  204. There are also a number of systematic reviews and meta
  205. analysis concluding, uh, cannabinoids may provide effective pain relief, especially
  206. in difficult to treat instances.
  207. There are dozens of farmer co dynamic mechanisms can happen
  208. whites, but specifically in relation to pain.
  209. The analgesic action of th C is attributed to it
  210. binding with CB one receptors prevalent along pain pathways in
  211. the CNS, where it has an inhibitory effect on calcium
  212. ion channels and therefore neurotransmitter availability.
  213. CBD has an algae zik action being associated with its
  214. agonists. Agon is, um of T R P v 15
  215. ht three and five ht.
  216. One A.
  217. Receptors. It's acidic form CBD a selectively inhibits cox two
  218. and therefore inflammatory prostaglandin production in a similar fashion thio
  219. nonsteroidal anti inflammatories, which give it a huge potential for
  220. replacing or augmenting other pain medications as within any drug
  221. or medicine, there are potential side effects.
  222. T H C is well known.
  223. Side effects that include euphoria and paranoia are the so
  224. called side effects that can also be used to therapeutic
  225. benefit. Include appetite, stimulation, sedation on increased memory loss.
  226. The letter has a huge relevance for PTSD sufferers re
  227. experiencing traumatic events.
  228. Side effects of CBD include drowsiness, gastrointestinal upset and nausea.
  229. While patients report these generally to be tolerable, a personalized
  230. medicine approach with slow tied direction generally mitigates the manifestation
  231. of most side effects in terms of interactions, drugs or
  232. substances that are processed by C Y.
  233. P. 4 50 enzymes.
  234. Uh uh, In terms of interactions, drugs or substances that
  235. are processed by C Y P for 50 enzymes have
  236. the potential to interact with cannabinoid medicines, especially given the
  237. involvement of C Y P three a four.
  238. In more than 60% of pharmaceutical drug metabolism, cannabinoids, especially
  239. CBD, have the potential to enhance or inhibit their metabolism.
  240. C Y p 4 50 Cautions of general in relation
  241. to medical cannabis and have yet to be correlated in
  242. human trials.
  243. Cannabinoids have the ability to both enhance and synergistically act
  244. with opioid medications.
  245. Teetsi particularly has the potential Azan opioid sparing action.
  246. They have bean proven interactions with one epilepsy drug clubbers
  247. um, and some research showing liver enzyme changes in Children
  248. administered CBD again.
  249. Careful tight rationing, ongoing monitoring as with any drug to
  250. avoid negative interactions on dhe adverse effects moving forward.
  251. Prominent cannabinoid researcher Ethan Russo and other thought leaders in
  252. the scientific community theorized that many difficult to treat and
  253. otherwise idiopathic conditions may be related to deficiency or dysfunction.
  254. In the e.
  255. C. S in Dimitrios is fibromyalgia multiple sclerosis, PB, Parkinson's
  256. disease. You're gonna make me do it again